Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 11 (4) , 291-300
- https://doi.org/10.1007/bf00874427
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- MitoxantroneDrugs, 1991
- Pharmacokinetics and Metabolism of MitoxantroneClinical Pharmacokinetics, 1990
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Intensive Single-Agent Mitoxantrone for Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1988
- Mitoxantrone: an active, new antitumor agent with an improved therapeutic indexCancer Treatment Reviews, 1987
- Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983